Excellence Awards - Shortlists Announced
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Excellence Awards – Shortlists Announced

27 Oct 2021 (Last Updated November 9th, 2021 15:58)

We are delighted to announce the shortlists for the 2021 Excellence Awards. Look out for the announcement of the winners in December along with our full Awards Report

The shortlist categories are divided into FOUR groups:

Excellence Categories – These categories look at achievements in our  core areas of excellence and include everything from Covid-19 Response to Social Impact.

Sector Excellence – These categories look at achievements within each individual market sub-sector and can include everything from notable business expansion through innovation to diversity and environmental initiatives.

Firms of the Year – These categories look at achievements by specific types of companies and includes everything from new market entrants to finance and legal firms.

Deals of the Year – The most notable finance and M&A deals from the research period.

 

*Please note that we also have awards for individuals, the winners of which will be announced in our Awards Report alongside the other category winners

Excellence Categories

BUSINESS EXPANSION

  • Ajinomoto Bio-Pharma
  • Arcus Biosciences, WuXi Biologics
  • Dot Compliance
  • Eli Lilly, Biologics
  • Excellims
  • GlaxoSmithKline (GSK)
  • Nexus
  • Regeneron
  • Samsung Biologics
  • Takeda
  • UCB, Microsoft

COVID-19 RESPONSE

  • Altimmune, DynPort
  • Bharat Biotech, Ocugen
  • CureVac
  • Destiny Pharma, SporeGen
  • Dynavax, Medigen
  • GlaxoSmithKline (GSK)
  • Intravacc, Celonic
  • Medicago
  • Moderna
  • Novartis, Molecular Partners
  • Oramed
  • Roche, Regeneron
  • SK, Novavax
  • Symvivo
  • Takeda
  • T-scan

ENVIRONMENTAL IMPACT

  • Alliance to Zero
  • Lloyd
  • The Sustainable Healthcare Coalition

INNOVATION

  • Exscientia, BMS
  • GlaxoSmithKline (GSK)
  • Nvidia
  • Piezo Motion
  • University of California, San Diego
  • University of California, Berkeley

PRODUCT LAUNCH

  • Chief.AI
  • Dot Compliance
  • Genoskin
  • Hetero
  • Idifarma
  • Indivior
  • Merck

RESEARCH AND DEVELOPMENT

  • Adagio Therapeutics
  • Ampio
  • BioMarin, Deep Genomics
  • Codiak, Sarepta
  • CRUK, Teon
  • Oxford University
  • Pfizer, BioNTech
  • Scancell

SAFETY

  • ArisGlobal
  • TransPerfect

SOCIAL IMPACT

  • The Altrui Foundation
  • Galt Pharmaceuticals
  • NGM Biopharmaceuticals
  • Oximio

Sector Excellence

CARDIOVASCULAR

  • Abbott
  • AstraZeneca
  • Humacyte

CENTRAL NERVOUS SYSTEM

  • AbbVie, Caraway
  • Biogen, Denali
  • Eli Lilly, Verge Genomics
  • Exscientia, Blue Oak
  • GlaxoSmithKline (GSK), Alector
  • Ipsen, Exicure
  • Janssen
  • PTC Therapeutics
  • Roche, UCB

CLINICAL TRIALS

  • AbbVie, Calico
  • CytoDyn, Biomm
  • Gilead, Novo Nordisk
  • Hoth Therapeutics, UCRI
  • Moderna
  • Novavax
  • Pfizer, BioNTech

DRUG DEVELOPMENT

  • Arcus Biosciences, WuXi Biologics
  • Arrowhead, Horizon
  • BioMarin
  • FUJIFILM Cellular Dynamics
  • GI Innovation
  • insitro
  • IQVIA
  • Merck
  • Roivant Sciences
  • UCB, Microsoft
  • Viking Therapeutics

IMMUNOLOGY

  • Amgen, Kyowa Kirin
  • Biogen, В Bio-Thera
  • Lilly, Rigel

INFECTIOUS DISEASES

  • Exscientia
  • Gilead Sciences
  • Halozyme, ViiV Healthcare
  • Takeda, Frazier
  • Vaxart, Altesa

MANUFACTURING

  • Amgen
  • BioNTech, Novartis
  • Cellares, Poseida Therapeutics
  • Eisai, Seikagaku
  • Irisys
  • Moderna, Lonza
  • Regeneron
  • Samsung Biologics
  • Sandoz
  • Takeda
  • Thermo Fisher Scientific
  • VIVEbiotech
  • WuXi AppTec, OXGENE

ONCOLOGY

  • AbbVie, I-Mab
  • Arcus Biosciences, WuXi Biologics
  • AstraZeneca, Daiichi Sankyo
  • Bayer, Triumvira Immunologics
  • Bristol-Myers Squibb (BMS), Agenus
  • Boehringer, Enara Bio
  • Byondis, Glycotope
  • CRUK, Teon
  • Eisai, BMS
  • Gilead, Tango Therapeutics
  • HiFiBiO
  • Revitope Oncology
  • Pfizer
  • Rhizen, Curon
  • Twist, Neogene
  • Umoja Biopharma

RESPIRATORY

  • Icosavax
  • Moderna
  • Partner Therapeutics
  • Pieris, Genentech
  • Verona

SUPPLY CHAIN

  • CalAmp
  • Merck, BioNTech
  • USP

Firm of the Year

DISRUPTOR

  • Beam Therapeutics
  • BeiGene
  • Blueprint Medicines
  • ClouDr
  • Exscientia
  • Five Prime Therapeutics
  • GI Innovation
  • Insitro
  • Nvidia
  • Zymergen

FINANCE

  • Bank of America
  • Barclays
  • Centerview Partners
  • Citigroup
  • Cowen
  • Evercore
  • Guggenheim Partners
  • JPMorgan Chase & Co/J.P. Morgan Securities
  • Jefferies
  • Lazard
  • Morgan Stanley
  • The Goldman Sachs Group

LEGAL

  • Allen & Overy
  • Cooley
  • Cravath, Swaine & Moore
  • Davis Polk & Wardwell
  • Freshfields Bruckhaus Deringer
  • Fried, Frank, Harris, Shriver & Jacobson
  • Goodwin Procter
  • Kirkland & Ellis
  • Latham & Watkins
  • Ropes & Gray
  • Simpson Thacher & Bartlett
  • Wachtell, Lipton, Rosen & Katz

NEWCOMER

  • Alphazyme
  • Beam Therapeutics
  • Insitro
  • Recursion Pharmaceuticals
  • Relay Therapeutics

PRIVATE EQUITY/VC

  • Bain Capital
  • BC Partners
  • EQT Partners
  • Hellman & Friedman
  • Pamplona Capital Management
  • Partners Group
  • Permira
  • The Blackstone Group
  • The Carlyle Group

SME

  • Beam Therapeutics
  • Five Prime Therapeutics
  • GI Innovation
  • Insitro
  • Revitope Oncology
  • Unchained Labs
  • Viking Therapeutics

Deal of the Year

FINANCE

  • Biomat
  • Everest Med
  • Hepalink
  • Legend Bio
  • Relay Tx
  • Remegen
  • Simcere
  • Sotera Health

M&A (impact)

  • AstraZeneca acquires Alexion
  • Danaher acquires Aldevron
  • Gilead Sciences acquires Immunomedics
  • Horizon acquires Viela Bio
  • Eli Lilly acquires Prevail Therapeutics
  • Merck & Co. acquires VelosBio
  • Nestlé acquires Aimmune Therapeutics
  • PerkinElmer acquires BioLegend
  • Thermo Fisher Scientific acquires PPD